title: Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance.
authors.affiliation: Section on Cellular and Molecular Physiology, Joslin Diabetes Center, Boston, Massachusetts, USA. jenny.gunton@joslin.harvard.edu
authors.forename: Jenny E
authors.initials: JE
authors.lastname: Gunton
authors.forename: N Wah
authors.initials: NW
authors.lastname: Cheung
authors.forename: Rosemary
authors.initials: R
authors.lastname: Hitchman
authors.forename: Graham
authors.initials: G
authors.lastname: Hams
authors.forename: Christine
authors.initials: C
authors.lastname: O'Sullivan
authors.forename: Kaye
authors.initials: K
authors.lastname: Foster-Powell
authors.forename: Aidan
authors.initials: A
authors.lastname: McElduff
mesh_terms: D019540:Area Under Curve; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D015992:Body Mass Index; D002857:Chromium / Q000008:administration & dosage / Q000494:pharmacology*; D019587:Dietary Supplements; D004311:Double-Blind Method; D018149:Glucose Intolerance / Q000097:blood*; D005951:Glucose Tolerance Test; D006801:Humans; D008055:Lipids / Q000097:blood; D010919:Placebos; D015203:Reproducibility of Results
chemical_list: D001786:Blood Glucose; D008055:Lipids; D010919:Placebos; D002857:Chromium